Lupin receives USFDA approval for generic drug to treat bronchoconstriction in COPD patients

Lupin receives USFDA approval for generic drug to treat bronchoconstriction in COPD patients

By, Admin 2 November 2022

The solution is the bioequivalent of Reference Listed Drug Brovana Inhalation Solution of Sunovion Pharmaceuticals Inc. Baltimore: Global pharma major Lupin Limited received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Arformoterol Tartrate Inhalation Solution 15 mcg (base)/2 ml unitdose vials. The solution is the bioequivalent of Reference Listed Drug Brovana Inhalation Solution of Sunovion Pharmaceuticals Inc. Unit-dose vials of Arformoterol Tartrate Inhalation Solution are indicated for the long-term maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. Arformoterol Tartrate Inhalation Solution can be administered through solely nebulization to the patient. According to IQVIA MAT December 2021, Arformoterol Tartrate Inhalation Solution had an estimated annual sales of USD 251 million in the United States pharmaceutical market.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!